In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate

Tunali M., Ozdemir H., KUCUKODACI Z., Akman S., Firatli E.

BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, vol.51, no.5, pp.438-443, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 5
  • Publication Date: 2013
  • Doi Number: 10.1016/j.bjoms.2012.08.003
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.438-443
  • Keywords: Tissue engineering, Biomaterial(s), Scanning electron microscopy (EM), In vivo, Biocompatibility, Regenerative medicine
  • Çanakkale Onsekiz Mart University Affiliated: No


We have developed a new, titanium-prepared, platelet-rich fibrin (T-PRF) together with the protocol for forming it, which is based on the hypothesis that titanium tubes may be more effective at activating platelets than the glass tubes used by Chouckroun in his platelet-rich fibrin (PRF) method. The aim of this study was to find a suitable animal model in which to evaluate the method and to investigate the efficacy of T-PRF for wound healing. Blood samples from 6 rabbits were used to confirm the protocol for formation of T-PRF. We evaluated T-PRF or T-PRF-like clots morphologically using scanning electron microscopy (EM). Blood samples from 5 rabbits were used to develop an experiment in which to evaluate the effects of T-PRF on wound healing. The mucoperiosteal flaps were filled with autologous T-PRF membranes from the vestibule in the anterior mandibular regions. Samples collected from the surgical sites were stained with haematoxylin and eosin. We found a mature fibrin network in T-PRF clots that had been centrifuged for 15 min at 3500 rpm and, 15 days after placement of the membrane, we found newly-forming connective tissue and islets of bony tissue in the T-PRF membrane. These results show that T-PRF could induce the formation of new bone with new connective tissue in a rabbit model of wound healing within 30 days of treatment. Published by Elsevier Ltd. on behalf of The British Association of Oral and Maxillofacial Surgeons.